26. HTLV-1-associated myelopathy Clinical trials / Disease details
Clinical trials : 29 / Drugs : 47 - (DrugBank : 29) / Drug target genes : 34 - Drug target pathways : 119
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00773292 (ClinicalTrials.gov) | August 2006 | 15/10/2008 | Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) | The HAM Ciclosporin Study : an Observational Trial of Therapy in Early or Progressing HAM/TSP | HTLV I Associated Myelopathy | Drug: ciclosporin | Imperial College London | Medical Research Council;University Hospital Birmingham;Imperial College Healthcare NHS Trust | Completed | 16 Years | 75 Years | All | 7 | Phase 2/Phase 3 | United Kingdom |